Why US biotech stocks are back in favor

Now watching

Next video starts in : 7 Play

Why US biotech stocks are back in favor

Why US biotech stocks are back in favor
Replay video
Up next

Urgency of Canada wildfire evacuations

Unlock your personal NFL Now stream by signing in to NFL.com

Why US biotech stocks are back in favor

by CNBC Videos 2:07 mins

While biotechnology shares are not cheap, they are no where near "bubble-like" valuations, says Bill Stone, Chief Investment Strategist at PNC Asset Management Group.

View Comments (0)